Nitroxolin Forte Chephasaar Chemisch-Pharmazeutische Fabrik (Nitroxoline)

Nitroxoline acts by chelating essential metal ions like iron and magnesium, which are cofactors for bacterial enzymes. This chelation inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription, and also interferes with metabolic pathways, resulting in a bacteriostatic effect against common urinary pathogens.

The appropriate dose of Nitroxolin Forte is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and severity of infection. Dosage regimens are individualized and should follow the prescriber’s instructions and local clinical guidelines.

The safety of nitroxoline in pregnancy and lactation has not been established. It is classified as pregnancy category unknown, and use should be limited to situations where the potential benefit justifies any potential risk to the fetus or infant. Consultation with a healthcare provider is essential.

To request Nitroxolin Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details, and any necessary import documentation.

Nitroxolin Forte offers a quinoline‑based mechanism distinct from beta‑lactams, fluoroquinolones, and nitrofurantoin. Its metal‑chelation property provides activity against some resistant Gram‑negative strains, and it is generally well tolerated. However, choice of therapy depends on local resistance patterns, patient allergies, and specific clinical circumstances.

Nitroxolin Forte should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout the shelf life.

Nitroxolin Forte is taken orally, usually with a full glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Administration timing (e.g., with or without food) follows the prescriber’s guidance.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis, hepatic dysfunction manifested by jaundice or elevated liver enzymes, blood dyscrasias like neutropenia, and severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if any of these occur.

Nitroxolin Forte should be avoided in individuals with known hypersensitivity to nitroxoline or any quinoline derivatives. Patients with severe renal impairment may require dose adjustment or alternative therapy. Pregnant or breastfeeding women should only use it if clearly indicated and after risk‑benefit assessment by a qualified clinician.